🔎 Trials Near Me

Avaleht › Kolesterool › California

Kolesterool kliinilised uuringud osariigis California

6 uuringut haiguse Kolesterool jaoks otsivad osalejaid osariigis California.

Ametlik uuringutekst (inglise keeles)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  • Pacific Oaks Medical Group, Beverly Hills
  • Cardiovascular Institute of San Diego, Chula Vista
  • John Muir Medical Center - Concord Campus, Concord
  • ja veel 10
VärbamineFaas 4
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT06909565

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

  • Research Site, Huntington Beach
  • Research Site, Loma Linda
  • Research Site, Lomita
  • ja veel 2
VärbamineFaas 3
Vanused 18–130 · Kõik sood · Uuendatud 10. sept 2026 · NCT07619131

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

  • Clinical Trials Research, Lincoln
  • Downtown L A Research Center Inc, Los Angeles
  • Valley Clinical Trials, Northridge
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 30. juuli 2026 · NCT07610278

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

  • UC San Francisco Medical Center, San Francisco
VärbamineFaas 3
Vanused 2–11 · Kõik sood · Uuendatud 24. juuli 2026 · NCT06597006

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

  • Anaheim Clinical Trials, Anaheim
  • Cenexel CNS, Los Alamitos
  • Diablo Clinical Research - Flourish Research, Walnut Creek
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 22. juuli 2026 · NCT07477704

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  • UC San Francisco Medical Center, San Francisco
  • UC San Francisco Medical Center, San Francisco
VärbamineFaas 3
Vanused 6–11 · Kõik sood · Uuendatud 15. mai 2026 · NCT06597019

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.